NO960268L - New dialkoxypyridinylbenzimidazole derivatives - Google Patents
New dialkoxypyridinylbenzimidazole derivativesInfo
- Publication number
- NO960268L NO960268L NO960268A NO960268A NO960268L NO 960268 L NO960268 L NO 960268L NO 960268 A NO960268 A NO 960268A NO 960268 A NO960268 A NO 960268A NO 960268 L NO960268 L NO 960268L
- Authority
- NO
- Norway
- Prior art keywords
- compounds
- methyl
- new
- dialkoxypyridinylbenzimidazole
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Nye optisk rene forbindelser, dvs de enantiomere enkeltforbindelsene (+)-5- karbometoksy-6-metyl-2-[[(3,4-dimetoksy-2-pyridinyl)metyl]sulfmyl]-l-[mandel- oyloksymetyl]-! H-benzimidazol og (-)-5-karbometoksy-6-metyl-2-[[(3,4-dimetoksy-2- pyridinyl)metyl]sulfinyl]-1 -[mandeloyloksymetyl]-1 H-benzimidazol eller et terapeutisk akseptabelt salt derav, slik som Na+, Mg2+, Li+, K+, Ca2+og N+(R)4 salter, hvor R er en alkylgruppe med 1-4 karbonatomer, fremgangsmåter for fremstilling derav og farma- søytiske preparater inneholdende forbindelsene som aktive bestanddeler, anvendelse av forbindelsene i farmasøytiske preparater samt mellomprodukter oppnådd ved frem- ' stilling av forbindelsene.New optically pure compounds, i.e. the enantiomeric single compounds (+) - 5-carbomethoxy-6-methyl-2 - [[(3,4-dimethoxy-2-pyridinyl) methyl] sulfmyl] -1- [almond oyloxymethyl] -! H-benzimidazole and (-) - 5-carbomethoxy-6-methyl-2 - [[(3,4-dimethoxy-2-pyridinyl) methyl] sulfinyl] -1 - [mandeloyloxymethyl] -1H-benzimidazole or a therapeutically acceptable salts thereof, such as Na +, Mg 2+, Li +, K +, Ca 2+ and N + (R) 4 salts, wherein R is an alkyl group of 1-4 carbon atoms, processes for their preparation and pharmaceutical preparations containing the compounds as active ingredients, use of the compounds in pharmaceutical preparations as well as intermediates obtained by the preparation of the compounds.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25617194A | 1994-05-27 | 1994-05-27 | |
SE9400511 | 1994-05-27 | ||
PCT/SE1995/000519 WO1995032959A1 (en) | 1994-05-27 | 1995-05-11 | Novel dialkoxy-pyridinyl-benzimidazole derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
NO960268L true NO960268L (en) | 1996-01-23 |
NO960268D0 NO960268D0 (en) | 1996-01-23 |
Family
ID=20392945
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO960268A NO960268D0 (en) | 1994-05-27 | 1996-01-23 | New dialkoxypyridinylbenzimidazole derivatives |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP0712401A1 (en) |
JP (1) | JPH09504557A (en) |
CN (1) | CN1128997A (en) |
AU (1) | AU2633095A (en) |
BR (1) | BR9506235A (en) |
CA (1) | CA2166988A1 (en) |
CZ (1) | CZ24396A3 (en) |
EE (1) | EE9600011A (en) |
FI (1) | FI960367A0 (en) |
HU (1) | HU9600005D0 (en) |
IL (1) | IL113604A0 (en) |
IS (1) | IS4321A (en) |
MA (1) | MA23563A1 (en) |
NO (1) | NO960268D0 (en) |
PL (1) | PL312692A1 (en) |
TN (1) | TNSN95062A1 (en) |
WO (1) | WO1995032959A1 (en) |
ZA (1) | ZA954125B (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9423968D0 (en) * | 1994-11-28 | 1995-01-11 | Astra Ab | Resolution |
GB9423970D0 (en) * | 1994-11-28 | 1995-01-11 | Astra Ab | Oxidation |
US5840737A (en) | 1996-01-04 | 1998-11-24 | The Curators Of The University Of Missouri | Omeprazole solution and method for using same |
US6489346B1 (en) | 1996-01-04 | 2002-12-03 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
KR100619200B1 (en) | 1998-11-18 | 2006-09-05 | 아스트라제네카 아베 | Improved Chemical Process and Pharmaceutical Formulation |
US8206741B2 (en) | 2001-06-01 | 2012-06-26 | Pozen Inc. | Pharmaceutical compositions for the coordinated delivery of NSAIDs |
US8993599B2 (en) | 2003-07-18 | 2015-03-31 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
US8906940B2 (en) | 2004-05-25 | 2014-12-09 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
US20080103169A1 (en) | 2006-10-27 | 2008-05-01 | The Curators Of The University Of Missouri | Compositions comprising acid labile proton pump inhibiting agents, at least one other pharmaceutically active agent and methods of using same |
AU2009215514B9 (en) | 2008-02-20 | 2014-01-30 | The Curators Of The University Of Missouri | Composition comprising a combination of omeprazole and lansoprazole, and a buffering agent, and methods of using same |
AU2009290712A1 (en) | 2008-09-09 | 2010-03-18 | Astrazeneca Ab | Method for delivering a pharmaceutical composition to patient in need thereof |
AU2010263304A1 (en) | 2009-06-25 | 2012-02-02 | Astrazeneca Ab | Method for treating a patient at risk for developing an NSAID-associated ulcer |
CA2860231A1 (en) | 2011-12-28 | 2013-07-04 | Pozen Inc. | Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2083606C (en) * | 1990-06-20 | 2001-08-21 | Arne Elof Brandstrom | Dialkoxy-pyridinyl-benzimidazole derivatives, process for their preparation and their pharmaceutical use |
DE4035455A1 (en) * | 1990-11-08 | 1992-05-14 | Byk Gulden Lomberg Chem Fab | ENANTIOMER SEPARATION |
-
1994
- 1994-05-29 TN TNTNSN95062A patent/TNSN95062A1/en unknown
-
1995
- 1995-05-03 IL IL11360495A patent/IL113604A0/en unknown
- 1995-05-11 CZ CZ96243A patent/CZ24396A3/en unknown
- 1995-05-11 JP JP8500730A patent/JPH09504557A/en active Pending
- 1995-05-11 CA CA002166988A patent/CA2166988A1/en not_active Abandoned
- 1995-05-11 EP EP95921187A patent/EP0712401A1/en not_active Withdrawn
- 1995-05-11 PL PL95312692A patent/PL312692A1/en unknown
- 1995-05-11 HU HU9600005A patent/HU9600005D0/en unknown
- 1995-05-11 BR BR9506235A patent/BR9506235A/en not_active Application Discontinuation
- 1995-05-11 WO PCT/SE1995/000519 patent/WO1995032959A1/en not_active Application Discontinuation
- 1995-05-11 AU AU26330/95A patent/AU2633095A/en not_active Abandoned
- 1995-05-11 CN CN95190482A patent/CN1128997A/en active Pending
- 1995-05-11 EE EE9600011A patent/EE9600011A/en unknown
- 1995-05-19 ZA ZA954125A patent/ZA954125B/en unknown
- 1995-05-26 MA MA23901A patent/MA23563A1/en unknown
-
1996
- 1996-01-17 IS IS4321A patent/IS4321A/en unknown
- 1996-01-23 NO NO960268A patent/NO960268D0/en unknown
- 1996-01-26 FI FI960367A patent/FI960367A0/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
FI960367A (en) | 1996-01-26 |
BR9506235A (en) | 1997-08-12 |
CZ24396A3 (en) | 1996-06-12 |
CA2166988A1 (en) | 1995-12-07 |
WO1995032959A1 (en) | 1995-12-07 |
IL113604A0 (en) | 1995-08-31 |
EE9600011A (en) | 1996-04-15 |
FI960367A0 (en) | 1996-01-26 |
ZA954125B (en) | 1995-11-27 |
CN1128997A (en) | 1996-08-14 |
AU2633095A (en) | 1995-12-21 |
HU9600005D0 (en) | 1996-03-28 |
IS4321A (en) | 1996-01-17 |
MA23563A1 (en) | 1995-12-31 |
PL312692A1 (en) | 1996-05-13 |
EP0712401A1 (en) | 1996-05-22 |
JPH09504557A (en) | 1997-05-06 |
NO960268D0 (en) | 1996-01-23 |
TNSN95062A1 (en) | 1996-02-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY121192A (en) | New compounds. | |
NO960268L (en) | New dialkoxypyridinylbenzimidazole derivatives | |
NO160204C (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE ALKALISTS OF 5-METOXY-2 (((4-METOXY-3,5-DIMETHYL-2-PYRIDINYL) -METHYL) -SULPHINYL) -1H-BENZIMIDAZOLE. | |
FI872864A0 (en) | Process for the preparation of pharmaceutically active benzimidazole derivatives | |
NO166126C (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE QUINOLONCARBOXYLIC ACID DERIVATIVES. | |
NO171915C (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 1-AZABICYCLO (4.2.0) OCT-2-DERIVATIVES | |
IL57324A (en) | 3-substituted-6-alkanoylamino-1,3,5-triazine-2,4-diones,process for their preparation and pharmaceutical compositions containing them | |
DE3767114D1 (en) | STABILIZED MEDICINAL PRODUCTS. | |
IL92799A0 (en) | Benzimidazole derivatives with gastric acid inhibition and process for its preparation | |
ES8100263A1 (en) | and analogy processes for the manufacture thereof. | |
NO960267L (en) | Newly substituted benzimidazoles | |
ES8303418A1 (en) | Benzo (4,5) pyrano (2,3c) pyrroles, processes for their preparation and pharmaceutical preparations containing same. | |
JO1871B1 (en) | Novel substituted benzimidazoles | |
JO1870B1 (en) | Novel dialkoxy - pyridinyl-benzimidazole derivatives | |
EP0192393A3 (en) | Alkylaminofuranone derivatives | |
FI893570A0 (en) | Process for the preparation of 1H-imidazo [1,2-b] pyrazole derivatives useful as medicaments | |
AU617849B2 (en) | New benzopyrrolidinone derivatives, a process for the preparation thereof and pharmaceutical compositions containing them | |
DE69000806D1 (en) | INDOL DERIVATIVES. | |
AU586707B2 (en) | New 2-(2-thienyl)-imidazo(4,5-c)pyridine derivatives and salts thereof, processes for their preparation and pharmaceutical products containing these | |
DK210387A (en) | HETEROCYCLIC RELATIONS AND PROCEDURES FOR THEIR PREPARATION AND PHARMACEUTICAL AGENTS CONTAINING THESE |